However, these degraders exhibited off-target effects and were less potent than their parent inhibitors in viability assays.399 Similar characteristics were observed in contemporaneous degraders MS4077 and MS4078.400 Kang et al. synthesized the VHL-based ALK degrader to realize the degradation of POIs and tumor inhibition. The gene discussed is ALK; the disease is neoplasm.